Androgen receptor and growth factor signaling cross-talk in prostate cancer cells

244Citations
Citations of this article
181Readers
Mendeley users who have this article in their library.

Abstract

Androgens promote the growth and differentiation of prostate cells through ligand activation of the androgen receptor (AR). Sensitization of the androgenic response by multifunctional growth factor signaling pathways is one of the mechanisms via which AR contributes to the emergence of androgen-independent prostate tumors. The ability of AR to cross-talk with key growth factor signaling events toward the regulation of cell cycle, apoptosis, and differentiation outcomes in prostate cancer cells is established. In this paper, we review the functional interaction between AR and an array of growth factor signal transduction events (including epidermal growth factor; fibroblast growth factor; IGF1; vascular endothelial growth factor; transforming growth factor-β) in prostate tumors. The significance of this derailed cross-talk between androgens and key signaling networks in prostate cancer progression and its value as a therapeutic forum targeting androgen-independent metastatic prostate cancer is discussed. © 2008 Society for Endocrinology.

Cite

CITATION STYLE

APA

Zhu, M. L., & Kyprianou, N. (2008, December). Androgen receptor and growth factor signaling cross-talk in prostate cancer cells. Endocrine-Related Cancer. https://doi.org/10.1677/ERC-08-0084

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free